{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:42:13Z","timestamp":1794663733393,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873443"],"award-info":[{"award-number":["81873443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070162"],"award-info":[{"award-number":["82070162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Translational Research Grant of NCRCH","award":["(2020ZKZC04)"],"award-info":[{"award-number":["(2020ZKZC04)"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["(BK20201169)"],"award-info":[{"award-number":["(BK20201169)"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Key Science Research Project of Jiangsu Commission of Health","award":["(K2019022)"],"award-info":[{"award-number":["(K2019022)"]}]},{"name":"Frontier Clinical Technical Project of\u00a0Suzhou\u00a0Science and Technology\u00a0plan","award":["(SKY2022001)"],"award-info":[{"award-number":["(SKY2022001)"]}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","award":["(BCF-IBW-XY-20220930-13)"],"award-info":[{"award-number":["(BCF-IBW-XY-20220930-13)"]}],"id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Suzhou\u00a0diagnosis and treatment project\u00a0of\u00a0Clinical\u00a0Key Diseases","award":["(LCZX202201)"],"award-info":[{"award-number":["(LCZX202201)"]}]},{"name":"the Priority Academic Program Development of Jiangsu Higher Education Institutions","award":["(PAPD)"],"award-info":[{"award-number":["(PAPD)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02022-z","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T03:17:06Z","timestamp":1727666226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Network pharmacology-based investigation and experimental validation of the mechanism of metformin in the treatment of acute myeloid leukemia"],"prefix":"10.1186","volume":"29","author":[{"given":"Shaoyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuofan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"2022_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98:502\u201326.","journal-title":"Am J Hematol"},{"issue":"2","key":"2022_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/10428194.2017.1330956","volume":"59","author":"JA Webster","year":"2018","unstructured":"Webster JA, Pratz KW. Acute myeloid leukemia in the elderly: therapeutic options and choice. Leuk Lymphoma. 2018;59(2):274\u201387.","journal-title":"Leuk Lymphoma."},{"issue":"9","key":"2022_CR3","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.3390\/curroncol29090491","volume":"29","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins RJ, Sanford D, et al. Management of acute myeloid leukemia: a review for general practitioners in oncology. Curr Oncol. 2022;29(9):6245\u201359.","journal-title":"Curr Oncol"},{"key":"2022_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu H. Emerging agents and regimens for AML. J Hematol Oncol. 2021;14:49.","journal-title":"J Hematol Oncol."},{"key":"2022_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375: n2026.","journal-title":"BMJ"},{"issue":"19","key":"2022_CR6","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1001\/jama.2019.3805","volume":"321","author":"J Flory","year":"2019","unstructured":"Flory J, Lipska K. Metformin in 2019. JAMA. 2019;321(19):1926\u20137.","journal-title":"JAMA"},{"key":"2022_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv Z, Guo Y. Metformin and its benefits for various diseases. Front Endocrinol. 2020;11:191.","journal-title":"Front Endocrinol"},{"key":"2022_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/biom13020250","volume":"13","author":"YZ Fang","year":"2023","unstructured":"Fang YZ, Chen B, et al. Action mechanism of metformin and its application in hematological malignancy treatments: a review. Biomolecules. 2023;13:250.","journal-title":"Biomolecules"},{"issue":"2","key":"2022_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales C, Schmidt HHHW, et al. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci. 2022;43(2):136\u201350.","journal-title":"Trends Pharmacol Sci."},{"key":"2022_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.952677","author":"Z Huang","year":"2022","unstructured":"Huang Z, Yang Y, Fan X, Ma W. Network pharmacology-based investigation and experimental validation of the mechanism of scutellarin in the treatment of acute myeloid leukemia. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.952677.","journal-title":"Front Pharmacol."},{"issue":"W1","key":"2022_CR11","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357\u201364.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2022_CR12","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362\u20138. https:\/\/doi.org\/10.1093\/nar\/gkw937.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2022_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Kumar AP, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"issue":"3","key":"2022_CR14","first-page":"253","volume":"5","author":"E Minet","year":"2000","unstructured":"Minet E, Michel G, Remacle J, Michiels C. Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (review). Int J Mol Med. 2000;5(3):253\u20139.","journal-title":"Int J Mol Med"},{"issue":"1","key":"2022_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29. https:\/\/doi.org\/10.1186\/s13045-023-01424-6.","journal-title":"J Hematol Oncol"},{"key":"2022_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155223","volume":"133","author":"CR Triggle","year":"2022","unstructured":"Triggle CR, Mohammed I, Bshesh K, Marei I, Ye K, Ding H, MacDonald R, Hollenberg MD, Hill MA. Metformin: is it a drug for all reasons and diseases? Metabolism. 2022;133: 155223.","journal-title":"Metabolism"},{"issue":"11","key":"2022_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682\u201390.","journal-title":"Nat Chem Biol"},{"issue":"8","key":"2022_CR18","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/ijms21082907","volume":"21","author":"I Nepstad","year":"2020","unstructured":"Nepstad I, Hatfield KJ, Gr\u00f8nnings\u00e6ter IS, Reikvam H. The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells. Int J Mol Sci. 2020;21(8):2907.","journal-title":"Int J Mol Sci"},{"issue":"698","key":"2022_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","volume":"25","author":"S Noorolyai","year":"2019","unstructured":"Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K\/AKT signaling pathway and cancer. Gene. 2019;25(698):120\u20138.","journal-title":"Gene"},{"key":"2022_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145796","volume":"798","author":"M Rashid","year":"2021","unstructured":"Rashid M, Zadeh LR, Baradaran B, Molavi O, Ghesmati Z, Sabzichi M, Ramezani F. Up-down regulation of HIF-1\u03b1 in cancer progression. Gene. 2021;798: 145796. https:\/\/doi.org\/10.1016\/j.gene.2021.145796.","journal-title":"Gene"},{"key":"2022_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101197","volume":"25","author":"T Liu","year":"2019","unstructured":"Liu T, Jin L, Chen M, Zheng Z, Deng W, et al. Ku80 promotes melanoma growth and regulates antitumor effect of melatonin by targeting HIF1-\u03b1 dependent PDK-1 signaling pathway. Redox Biol. 2019;25: 101197.","journal-title":"Redox Biol"},{"issue":"1","key":"2022_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/cbdd.13860","volume":"98","author":"P Yadav","year":"2021","unstructured":"Yadav P, Yadav R, Jain S, Vaidya A. Caspase-3: a primary target for natural and synthetic compounds for cancer therapy. Chem Biol Drug Des. 2021;98(1):144\u201365.","journal-title":"Chem Biol Drug Des"},{"issue":"627","key":"2022_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.gene.2017.06.035","volume":"5","author":"KK Gundapaneni","year":"2017","unstructured":"Gundapaneni KK, Shyamala N, Galimudi RK, Hanumanth SR, et al. Polymorphic variants of Caspase genes (8 & 3) in the risk prediction of Coronary Artery Disease. Gene. 2017;5(627):278\u201383.","journal-title":"Gene"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02022-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T03:24:29Z","timestamp":1727666669000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02022-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02022-z","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"475"}}